A pilot study on the use of low dose erythropoietin in the management of human immunodeficiency virus (HIV) associated anaemia in Uganda
Completed
- Conditions
- HIV associated anaemiaHaematological DisordersOther anaemias
- Registration Number
- ISRCTN40084595
- Lead Sponsor
- Star Pharmaceuticals Ltd (Uganda)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
1. Documented HIV positive
2. Grade 1 and 2 anaemia
3. Informed consent
4. Age 18 to 65 years
Exclusion Criteria
1. Recent blood loss
2. Active opportunistic infection
3. Presence of fever at the time of enrolment
4. Pregnancy
5. Cancer chemotherapy
6. Severe microcytosis
7. Systemic hypertension
8. Known allergy to erythropoietin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method